Geode Capital Management’s Salarius Pharmaceuticals SLRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.9K | Buy |
15,560
+4,057
| +35% | +$3.63K | ﹤0.01% | 4405 |
|
2025
Q1 | $8.67K | Buy |
+11,503
| New | +$8.67K | ﹤0.01% | 4438 |
|
2024
Q2 | – | Sell |
-24,771
| Closed | -$13.1K | – | 4620 |
|
2024
Q1 | $13.1K | Hold |
24,771
| – | – | ﹤0.01% | 4530 |
|
2023
Q4 | $15.9K | Hold |
24,771
| – | – | ﹤0.01% | 4547 |
|
2023
Q3 | $16.4K | Buy |
24,771
+8,248
| +50% | +$5.46K | ﹤0.01% | 4660 |
|
2023
Q2 | $24.6K | Hold |
16,523
| – | – | ﹤0.01% | 4632 |
|
2023
Q1 | $31.7K | Hold |
16,523
| – | – | ﹤0.01% | 4617 |
|
2022
Q4 | $25K | Sell |
16,523
-396,612
| -96% | -$600K | ﹤0.01% | 4734 |
|
2022
Q3 | $80K | Hold |
413,135
| – | – | ﹤0.01% | 4652 |
|
2022
Q2 | $86K | Buy |
413,135
+23,020
| +6% | +$4.79K | ﹤0.01% | 4642 |
|
2022
Q1 | $155K | Hold |
390,115
| – | – | ﹤0.01% | 4496 |
|
2021
Q4 | $193K | Buy |
390,115
+34,001
| +10% | +$16.8K | ﹤0.01% | 4491 |
|
2021
Q3 | $363K | Buy |
356,114
+79,079
| +29% | +$80.6K | ﹤0.01% | 4177 |
|
2021
Q2 | $293K | Buy |
277,035
+153,574
| +124% | +$162K | ﹤0.01% | 4172 |
|
2021
Q1 | $182K | Buy |
123,461
+105,131
| +574% | +$155K | ﹤0.01% | 4141 |
|
2020
Q4 | $16K | Hold |
18,330
| – | – | ﹤0.01% | 4261 |
|
2020
Q3 | $15K | Hold |
18,330
| – | – | ﹤0.01% | 4132 |
|
2020
Q2 | $24K | Hold |
18,330
| – | – | ﹤0.01% | 4058 |
|
2020
Q1 | $12K | Hold |
18,330
| – | – | ﹤0.01% | 4070 |
|
2019
Q4 | $69K | Buy |
+18,330
| New | +$69K | ﹤0.01% | 4039 |
|
2019
Q3 | – | Sell |
-175,716
| Closed | -$97K | – | 4234 |
|
2019
Q2 | $97K | Buy |
175,716
+118,778
| +209% | +$65.6K | ﹤0.01% | 3969 |
|
2019
Q1 | $21K | Hold |
56,938
| – | – | ﹤0.01% | 4089 |
|
2018
Q4 | $18K | Hold |
56,938
| – | – | ﹤0.01% | 4096 |
|
2018
Q3 | $26K | Hold |
56,938
| – | – | ﹤0.01% | 4081 |
|
2018
Q2 | $53K | Hold |
56,938
| – | – | ﹤0.01% | 3970 |
|
2018
Q1 | $284K | Hold |
56,938
| – | – | ﹤0.01% | 3589 |
|
2017
Q4 | $198K | Sell |
56,938
-2,822
| -5% | -$9.81K | ﹤0.01% | 3681 |
|
2017
Q3 | $203K | Hold |
59,760
| – | – | ﹤0.01% | 3667 |
|
2017
Q2 | $230K | Sell |
59,760
-21,226
| -26% | -$81.7K | ﹤0.01% | 3634 |
|
2017
Q1 | $356K | Buy |
80,986
+4,544
| +6% | +$20K | ﹤0.01% | 3447 |
|
2016
Q4 | $403K | Buy |
76,442
+2,012
| +3% | +$10.6K | ﹤0.01% | 3349 |
|
2016
Q3 | $876K | Buy |
74,430
+2,002
| +3% | +$23.6K | ﹤0.01% | 3008 |
|
2016
Q2 | $739K | Buy |
72,428
+7,640
| +12% | +$78K | ﹤0.01% | 3042 |
|
2016
Q1 | $710 | Sell |
64,788
-54
| -0.1% | -$1 | ﹤0.01% | 3056 |
|
2015
Q4 | $807K | Buy |
64,842
+614
| +1% | +$7.64K | ﹤0.01% | 3026 |
|
2015
Q3 | $771K | Buy |
64,228
+2,514
| +4% | +$30.2K | ﹤0.01% | 3024 |
|
2015
Q2 | $1.06M | Buy |
+61,714
| New | +$1.06M | ﹤0.01% | 2860 |
|